All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This gene is closely related to several other genes clustered on chromosome X. These genes may be overexpressed in tumors. Multiple alternatively spliced variants encoding the same protein have been identified.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-L059 | Human anti-MAGEA12 (VRIGHLYIL) T Cell Receptor, pMSGV1 | Human | Human | VRIGHLYIL | HLA-Cw7 | retroviral vector | ||
TCR-L058Z | Human anti-MAGEA12 (aa169-178) T cell receptor, pCDTCR1 | Human | Human | VRIGHLYIL | HLA-Cw7 | Lentiviral | ||
TCR-C116Z | Mouse anti-MAGE-A12 (KMAELVHFL) T cell receptor, pCDTCR1 | Human | Mouse | KMAELVHFL | HLA-A*0201 | Lentiviral | ||
TCR-C117Z | Human anti-MAGE-A12 T cell receptor (502), pCDTCR1 | Human | 502 | Human | aa 170-178 | HLA-C*07 | Lentiviral | |
TCR-C118Z | Human anti-MAGE-A12 T cell receptor (FM8), pCDTCR1 | Human | FM8 | Human | aa 170-178 | HLA-C*07 | Lentiviral |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION